Health Tip: Preventing Falls Among the Elderly
(HealthDay News) -- Of all fall-related deaths, more than 60
percent involve people who are 75 years old or older. According to
the Brain Injury Association of America, falls are a leading cause
of traumatic brain injury among the elderly.
Hurricanes Linked to Raised 'Fetal Distress' Risk
MONDAY, Oct. 18 (HealthDay News) -- Exposure to hurricanes while
still in the womb may increase risk of fetal distress, which can
cause long-range health problems after birth, new research
Hospital Collaboration May Boost Surgical Patient Safety
MONDAY, Oct. 18 (HealthDay News) -- The rate of surgical
complications decreased nearly 10 percent at 16 Michigan hospitals
after they began to share information about what methods they use
to keep patients safe, a new study has found.
Soy May Reduce Breast Cancer Recurrence: Study
MONDAY, Oct. 18 (HealthDay News) -- For women past menopause who
have had breast cancer, a higher intake of soy may help reduce the
risk of the disease's recurrence, a new study of Chinese women
H1N1 Unlikely to Cause Flu Pandemic in 2010-11: Analysis
MONDAY, Oct. 18 (HealthDay News) -- Canadian researchers say
they do not expect the H1N1 virus -- the so-called swine flu -- to
be very severe this year, although they are recommending that
everyone over the age of 50, especially those with chronic health
conditions, get immunized this fall.
Fewer Bone Screens May Be OK for Some Older Women
MONDAY, Oct. 18 (HealthDay News) -- Older women may be able to
safely avoid getting bone density tests for 10 years if their
previous screening scores didn't show signs of problems, a new
Botox Approved for Chronic Migraines
MONDAY, Oct. 18 (HealthDay News) -- Botox (onabotulinumtoxinA)
injection has been approved by the U.S. Food and Drug
Administration to prevent chronic migraines among people who get
the painful headaches more than 14 days per month.
Can Vitamin B12 Reduce Alzheimer's Risk?
MONDAY, Oct. 18 (HealthDay News) -- People who eat a diet rich
in vitamin B12 may be protecting themselves from Alzheimer's
disease, a small, preliminary study suggests.
Baraclude Sanctioned for Severe Liver Disease
MONDAY, Oct. 18 (HealthDay News) -- Bristol-Myers Squibb said
Monday its liver drug Baraclude (entecavir) has received expanded
approval from the U.S. Food and Drug Administration to treat
chronic hepatitis B in adults with decompensated liver disease, a
form of severe liver damage.